Loading

Journal of Veterinary Medicine and Research

Severe Orf in Lambs: Clinical Description and Response to Treatment against Secondary Infection

Case Report | Open Access

  • 1. Department of Animal Welfare and Animal Management Moulton College, USA
  • 2. University of Northampton, School of Science and Technology, USA
  • 3. Department of Veterinary Medicine Stag Hill Campus, University of Surrey Guildford, USA
+ Show More - Show Less
Corresponding Authors
Joshua Onyango, University of Northampton, School of Science and Technology, St Georges Avenue, Northampton NN2 6JD, USA
Abstract

In May 2014, severe disease affecting areas around the muzzle and the entire buccal mucosa was observed in two lambs from a flock of approximately 200 Highlander and Charolaise ewes. The lambs were ten weeks old. Clinical signs ofproliferative lesions around the mucocutanous junction of the mouth and the presence of scabs extending for 4 to 6 cm around the muzzlewere supportive of severe orf. No laboratory test was undertaken. It was therefore deemed necessary to offer treatment against secondary infection. Both lambs responded very well to a combination of 200mg/kg procaine penicillin and 250mg/kg body weight dihydrostreptomycin sulphateand 1,5 pentanedial in petroleum based soft emollient cream administered once daily for three consecutive days. The treatment regime showed that secondary infection during severe orf cases can be treated with penicillin-streptomycin and petroleum based soft emollient cream in order to reduce losses associated with the disease.

Keywords


•    Orf
•    Lambs
•    Clinical signs
•    Treatment
•    Penicillin
•    Dihydro streptomycin sulphate

Citation

CertAH JO, McCormick W, Chapman S (2014) Severe Orf in Lambs: Clinical Description and Response to Treatment against Secondary Infection. J Vet Med Res 1(2): 1007

INTRODUCTION

ORF, also known as scabby mouth, contagious ecthyma, contagious pustular dermatitis is a viral disease caused by Parapoxvirus (Orf virus) that affects sheep, goats, camels and other species including humans [1,2]. Scarification or macroabrasions of the epidermis is necessary before the disease can occur. Clinical presentation is more severe in lambs causing proliferative lesions around the mucocutanous junction of the mouth. Overall, the clinical picture of the disease has been characterised by formation of scabs and proliferation of the epidermis causing painful lesions on the vulva, udder and teats in ewes; whilst in lambs the lesions affect the mouth, nostrils, and lips extending to the oesophagus, and in some cases progressing to the hooves causing strawberry foot rot [3,4]. Secondary bacterial infection involving Staphylococcus aureus and Arcanobacterium pyogenes have been reported during orf cases [5]. The incubation period is relatively short and first signs can be noted from day four in lambs and this may persist for up to three weeks or longer; whilstfull recovery can take up to 8 weeks [6].

Orf can cause welfare and economic impacts usually associated with poor growth in lambs, mastitis in ewes and death in worst case scenarios [7]. A live attenuated vaccine is available,although this can only provide immunity for a maximum period of one year. The low efficacy of the vaccine has been attributed to host immune response mechanisms whereby the virus hasdevelopedmechanisms that can enable it to evade the immune response [8]. Also the heterogeneity among orfvirushas been linked to poor vaccine efficacy [9]. The disease can be diagnosed by veterinarians or more experienced sheep farmers and shepherds based on clinical signs in particular characteristic proliferative lesions around nostrils and lips,however, definitive diagnosisrequires electron microscopy or polymerase chain reaction tests [10].

CASE PRESENTATION

This case presentation reports a severe outbreak and treatment of orf in two lambs, which responded well to a combination of 200mg/kg procaine penicillin and 250mg/kg body weight dihydrostreptomycin sulphateand 1,5 pentanedial in petroleum based soft emollient cream. During May 2014, a flock of approximately 200 Highlander and Charolaise ewes flock with 300 lambs born in March 2014was visited to investigate on cases of orf. We diagnosed the cases based on clinical signs with no samples taken for confirmatory diagnosis. Several studies have documented that orf can often be diagnosed via clinical signs such as proliferative lesions on the skin around the lips and muzzle in ewes and lambs [1]. Around 30 lambs were found with signs of orf with two lambs presenting with severe signs of the disease. The two lambs that became of further interest showed signs of severe weight loss, probably due to the fact that they could not eat due to the severe painful lesions around the muzzle extending to the buccal mucosa. Rostraly, scabs were clearly visible extending for 4 to 6 cm around the muzzle. On careful removal of the scabs, there was bleeding and serous exudate with pus accumulation, characteristic of a secondary bacterial infection (Figure 1). In addition, lymphadenopathy involving both prefemoral and prescapular lymph nodes was noted. According to the farmer he had noticed a few lambs with orf 10 days before our visit. However, looking at the severity of the two cases the disease may have started much earlier.

We therefore focused around the two lambs to try administering some treatment against secondary infection. Tofacilitate wound healing and treatment for secondary infection the two lambs were given an intramuscular injection of 200mg/kg body weight procaine penicillin and 250mg/kg body weight dihydrostreptomycin sulphate [11] combined with 1,5 pentanedial in petroleum-based soft emollient cream once daily for three consecutive days. The choice for administering penicillin-dihydrostreptomycin sulphate combination was based on the fact that it has a broad spectrum activity against a wide range of pathogenic micro-organisms such as Arcanobacteriumpyogenes, Staphylococcus spp, Streptococcus spp and Salmonella spp,Klebsiella pneumonia, Listeria spp, Mannheimiahaemolyticaand Pasteurellamultocida [11]. When reexamined seven days later, the lesions had improved (Figure 2) and after two weeks the majority of scabs had almost cleared to a certain degree (Figure 3).

DISCUSSION

Orf is commonly seen soon after lambing and appears to occur during spring and summer months. It is caused by a parapox virus in the family Poxviridae. The prevalence of the disease varies between farms and this has been linked to management practices such as vaccination and other on farm biosecurity measures [12]. Though it can produce lesions elsewhere on the open surfaces of the skin, the common early signs involve papulovesicular eruption on the lips and mucocutanous junction of the mouth [5]. A vaccine is available but only provides immunity for up to 1 year. The disease can become much worse when opportunistic pathogens such as Staphylococcus aureus and Arcanobacteriumpyogenes are involved resulting in secondary bacterial infection. The present study looked at clinical presentation and therapeutic efficacy of procaine penicillin and dihydrostreptomycin sulphate [11] combined with 1,5 pentanedial in petrolatum based soft emollient cream (NET TEXTM) on two orf cases associated with secondary bacterial infection. Previous studies have concentrated around the use of antibiotics and antivirals but it is our understanding that no published work has employed symptomatic treatment involving parenteral procaine penicillin and dihydrostreptomycin sulphate and topical application of 1,5 pentanedial in petroleum based soft emollient cream against severe erythematous orf. It would be important to note that there are no treatments for orf due to the fact that it is a viral infection and thus any treatment is always focused around secondary infections. Most orf cases can last for up to eight weeks before the lambs recover fully while deaths have been reported during severe cases [5]. In the present study the lesions resolved within three weeks and both lambs showed good prognosis after treatment. Studies have shown that procaine penicillin and dihydrostreptomycin sulphate can have an extended spectrum of activity against target pathogens such as Arcanobacteriumpyogenes, Klebsiella pneumonia, Staphylococcus spp, Streptococcus spp and Salmonella spp [13]. Though this study did not go as far as identifying the pathogens which might have been present, Wilson and others [5] isolated Staphylococcus aureus and Arcanobacteriumpyogenesas some of the bacterial pathogens that were present during a severe orf outbreak in lambs. Studies conducted to test the safety and efficacy of 1,5-pentanediol petroleum based emollient showed a safety margin of 36.53% when used on dermatitis cases in humans [14]. The product also restored the skin barrier by increasing amount of lipids within the skin. The current product (1,5-pentanediol cream) applied around orf lesions may have worked by helping soften the scabs while restoring the skin barrier, similar to previous efficacy studies on dermatitis cases in humans.

There was a history of the farm having had orf 3 years ago after having bought feeding troughs from an agricultural auction market, which could have been a possible source of infection. It has also been documented that the virus can remain in buildings, soil or pasture for a long period while infected animals can remain carriers [15] which also could explain the occurrence of reported cases. The good prognosis to treatment did demonstrate that a combination of broad spectrum parenteral procaine penicillin and dihydrostreptomycin sulphate and topical application of 1,5 pentanedial in petrolatum based soft emollient cream is effective in the treatment against secondary infection during orf cases.

CONCLUSION

This study established that parenteral procaine penicillin and dihydrostreptomycin sulphate and topical application of 1,5 pentanedial in petroleum based soft emollient cream is effective in the treatment against secondary infections that followed during an orf outbreak in lambs. It is important to note that this study did not carry out any diagnostic tests to identify the specific pathogens present. It would be beneficial to carry out early treatment involving both parenteral and topical applications which could help reduce some of the health and welfare consequences associated with the disease. It would also be worth trying a similar type of treatment on a larger cross sectional study in future studiesfor more accurate results.

ACKNOWLEDGEMENTS

We would like to thank the sheep farmer for his support throughout the study

REFERENCES

1. Lovatt FM, Barker WJ, Brown D, Spooner RK. Case-control study of orf in preweaned lambs and an assessment of the financial impact of the disease. See comment in PubMed Commons below Vet Rec. 2012; 170: 673.

2. Ulug M, Urez MS, Bilgili ME. A viral infection of the hands: Orf. J of Microbiology and Infectious Diseases. 2013; 3: 41-44.

3. Abu EM, Housawi FM. Drastic cutaneous multi-focal orf infection in goats, causing severe dysfunctioning. See comment in PubMed Commons below Rev Sci Tech. 2009; 28: 1025-1029.

4. Aitken ID. Diseases of Sheep, 4th ed. Can Vet J. 2008; 49: 702.

5. Wilson DJ, Scott PR, Sargison ND, Bell G, Rhind SM. Effective treatment of severe facial dermatitis in lambs. Vet Rec. 2002; 150: 45-46.

6. Nandi S, Ujjwal K, Choudhury S. Current status of contagious ecthyma or orf disease in goat and sheep - A global perspective. Small Ruminant Research. 2010; 96: 73-82.

7. Kinley GE, Schmitt CW, Stephens-Devalle J. A Case of Contagious Ecthyma (Orf Virus) in a Nonmanipulated Laboratory Dorset Sheep (Ovis aries). Case Reports in Veterinary Medicine. 2013. 210854.

8. Haig DM, McInnes C, Deane D, Reid H, Mercer A. The immune and inflammatory response to orf virus. See comment in PubMed Commons below Comp Immunol Microbiol Infect Dis. 1997; 20: 197- 204.

9. Zhao K, He W, Gao W, Lu H, Han T, Li J, et al. Orf virus DNA vaccines expressing ORFV 011 and ORFV 059 chimeric protein enhances immunogenicity. Virol J. 2011; 8: 562.

10. Ramesh A, Vadivoo VS, Suresh Babu S, Saravanabava K. Confirmatory diagnosis of contagious ecthyma by amplification of the gif / il-2 gene by PCR. Tamilnadu J of Vet and Anim Sci. 2008: 4; 208 – 210.

11. Norbrook Product Compendium. 2014.

12. Onyango J, Mata F, McCormick W, Chapman S. Prevalence, risk factors and vaccination efficacy of contagious ovine ecthyma (orf) in England. Vet Rec. 2014.

13. Schwarz S, Werckenthin C, Alesík E, Wieler LH, Wallmann J. Susceptibility of bacterial pathogens against lincomycin/ spectinomycin (1/2), penicillin G/neomycin (1/1), and penicillin G/dihydrostreptomycin (1/1) as determined in the BfT-GermVet monitoring program 2004-2006. Berliner und Munchener Tierarztliche Wochenschrift. 2007; 120: 363-371.

14. Raposo S,SalgadoA, Gonçalves L, Pinto PC, Urbano M, Ribeiro HM. Safety Assessment and Biological Effects of a New Cold Processed SilEmulsion for Dermatological Purpose. BioMed Research International. 2013. 181634.

15. Nettleton PF, Gilray JA, Yirrell DL, Scott GR, Reid HW. Natural transmission of orf virus from clinically normal ewes to orf-naive sheep. See comment in PubMed Commons below Vet Rec. 1996; 139: 364-366.

Received : 10 Jul 2014
Accepted : 28 Aug 2014
Published : 28 Aug 2014
Journals
Annals of Otolaryngology and Rhinology
ISSN : 2379-948X
Launched : 2014
JSM Schizophrenia
Launched : 2016
Journal of Nausea
Launched : 2020
JSM Internal Medicine
Launched : 2016
JSM Hepatitis
Launched : 2016
JSM Oro Facial Surgeries
ISSN : 2578-3211
Launched : 2016
Journal of Human Nutrition and Food Science
ISSN : 2333-6706
Launched : 2013
JSM Regenerative Medicine and Bioengineering
ISSN : 2379-0490
Launched : 2013
JSM Spine
ISSN : 2578-3181
Launched : 2016
Archives of Palliative Care
ISSN : 2573-1165
Launched : 2016
JSM Nutritional Disorders
ISSN : 2578-3203
Launched : 2017
Annals of Neurodegenerative Disorders
ISSN : 2476-2032
Launched : 2016
Journal of Fever
ISSN : 2641-7782
Launched : 2017
JSM Bone Marrow Research
ISSN : 2578-3351
Launched : 2016
JSM Mathematics and Statistics
ISSN : 2578-3173
Launched : 2014
Journal of Autoimmunity and Research
ISSN : 2573-1173
Launched : 2014
JSM Arthritis
ISSN : 2475-9155
Launched : 2016
JSM Head and Neck Cancer-Cases and Reviews
ISSN : 2573-1610
Launched : 2016
JSM General Surgery Cases and Images
ISSN : 2573-1564
Launched : 2016
JSM Anatomy and Physiology
ISSN : 2573-1262
Launched : 2016
JSM Dental Surgery
ISSN : 2573-1548
Launched : 2016
Annals of Emergency Surgery
ISSN : 2573-1017
Launched : 2016
Annals of Mens Health and Wellness
ISSN : 2641-7707
Launched : 2017
Journal of Preventive Medicine and Health Care
ISSN : 2576-0084
Launched : 2018
Journal of Chronic Diseases and Management
ISSN : 2573-1300
Launched : 2016
Annals of Vaccines and Immunization
ISSN : 2378-9379
Launched : 2014
JSM Heart Surgery Cases and Images
ISSN : 2578-3157
Launched : 2016
Annals of Reproductive Medicine and Treatment
ISSN : 2573-1092
Launched : 2016
JSM Brain Science
ISSN : 2573-1289
Launched : 2016
JSM Biomarkers
ISSN : 2578-3815
Launched : 2014
JSM Biology
ISSN : 2475-9392
Launched : 2016
Archives of Stem Cell and Research
ISSN : 2578-3580
Launched : 2014
Annals of Clinical and Medical Microbiology
ISSN : 2578-3629
Launched : 2014
JSM Pediatric Surgery
ISSN : 2578-3149
Launched : 2017
Journal of Memory Disorder and Rehabilitation
ISSN : 2578-319X
Launched : 2016
JSM Tropical Medicine and Research
ISSN : 2578-3165
Launched : 2016
JSM Head and Face Medicine
ISSN : 2578-3793
Launched : 2016
JSM Cardiothoracic Surgery
ISSN : 2573-1297
Launched : 2016
JSM Bone and Joint Diseases
ISSN : 2578-3351
Launched : 2017
JSM Bioavailability and Bioequivalence
ISSN : 2641-7812
Launched : 2017
JSM Atherosclerosis
ISSN : 2573-1270
Launched : 2016
Journal of Genitourinary Disorders
ISSN : 2641-7790
Launched : 2017
Journal of Fractures and Sprains
ISSN : 2578-3831
Launched : 2016
Journal of Autism and Epilepsy
ISSN : 2641-7774
Launched : 2016
Annals of Marine Biology and Research
ISSN : 2573-105X
Launched : 2014
JSM Health Education & Primary Health Care
ISSN : 2578-3777
Launched : 2016
JSM Communication Disorders
ISSN : 2578-3807
Launched : 2016
Annals of Musculoskeletal Disorders
ISSN : 2578-3599
Launched : 2016
Annals of Virology and Research
ISSN : 2573-1122
Launched : 2014
JSM Renal Medicine
ISSN : 2573-1637
Launched : 2016
Journal of Muscle Health
ISSN : 2578-3823
Launched : 2016
JSM Genetics and Genomics
ISSN : 2334-1823
Launched : 2013
JSM Anxiety and Depression
ISSN : 2475-9139
Launched : 2016
Clinical Journal of Heart Diseases
ISSN : 2641-7766
Launched : 2016
Annals of Medicinal Chemistry and Research
ISSN : 2378-9336
Launched : 2014
JSM Pain and Management
ISSN : 2578-3378
Launched : 2016
JSM Women's Health
ISSN : 2578-3696
Launched : 2016
Clinical Research in HIV or AIDS
ISSN : 2374-0094
Launched : 2013
Journal of Endocrinology, Diabetes and Obesity
ISSN : 2333-6692
Launched : 2013
Journal of Substance Abuse and Alcoholism
ISSN : 2373-9363
Launched : 2013
JSM Neurosurgery and Spine
ISSN : 2373-9479
Launched : 2013
Journal of Liver and Clinical Research
ISSN : 2379-0830
Launched : 2014
Journal of Drug Design and Research
ISSN : 2379-089X
Launched : 2014
JSM Clinical Oncology and Research
ISSN : 2373-938X
Launched : 2013
JSM Bioinformatics, Genomics and Proteomics
ISSN : 2576-1102
Launched : 2014
JSM Chemistry
ISSN : 2334-1831
Launched : 2013
Journal of Trauma and Care
ISSN : 2573-1246
Launched : 2014
JSM Surgical Oncology and Research
ISSN : 2578-3688
Launched : 2016
Annals of Food Processing and Preservation
ISSN : 2573-1033
Launched : 2016
Journal of Radiology and Radiation Therapy
ISSN : 2333-7095
Launched : 2013
JSM Physical Medicine and Rehabilitation
ISSN : 2578-3572
Launched : 2016
Annals of Clinical Pathology
ISSN : 2373-9282
Launched : 2013
Annals of Cardiovascular Diseases
ISSN : 2641-7731
Launched : 2016
Journal of Behavior
ISSN : 2576-0076
Launched : 2016
Annals of Clinical and Experimental Metabolism
ISSN : 2572-2492
Launched : 2016
Clinical Research in Infectious Diseases
ISSN : 2379-0636
Launched : 2013
JSM Microbiology
ISSN : 2333-6455
Launched : 2013
Journal of Urology and Research
ISSN : 2379-951X
Launched : 2014
Journal of Family Medicine and Community Health
ISSN : 2379-0547
Launched : 2013
Annals of Pregnancy and Care
ISSN : 2578-336X
Launched : 2017
JSM Cell and Developmental Biology
ISSN : 2379-061X
Launched : 2013
Annals of Aquaculture and Research
ISSN : 2379-0881
Launched : 2014
Clinical Research in Pulmonology
ISSN : 2333-6625
Launched : 2013
Journal of Immunology and Clinical Research
ISSN : 2333-6714
Launched : 2013
Annals of Forensic Research and Analysis
ISSN : 2378-9476
Launched : 2014
JSM Biochemistry and Molecular Biology
ISSN : 2333-7109
Launched : 2013
Annals of Breast Cancer Research
ISSN : 2641-7685
Launched : 2016
Annals of Gerontology and Geriatric Research
ISSN : 2378-9409
Launched : 2014
Journal of Sleep Medicine and Disorders
ISSN : 2379-0822
Launched : 2014
JSM Burns and Trauma
ISSN : 2475-9406
Launched : 2016
Chemical Engineering and Process Techniques
ISSN : 2333-6633
Launched : 2013
Annals of Clinical Cytology and Pathology
ISSN : 2475-9430
Launched : 2014
JSM Allergy and Asthma
ISSN : 2573-1254
Launched : 2016
Journal of Neurological Disorders and Stroke
ISSN : 2334-2307
Launched : 2013
Annals of Sports Medicine and Research
ISSN : 2379-0571
Launched : 2014
JSM Sexual Medicine
ISSN : 2578-3718
Launched : 2016
Annals of Vascular Medicine and Research
ISSN : 2378-9344
Launched : 2014
JSM Biotechnology and Biomedical Engineering
ISSN : 2333-7117
Launched : 2013
Journal of Hematology and Transfusion
ISSN : 2333-6684
Launched : 2013
JSM Environmental Science and Ecology
ISSN : 2333-7141
Launched : 2013
Journal of Cardiology and Clinical Research
ISSN : 2333-6676
Launched : 2013
JSM Nanotechnology and Nanomedicine
ISSN : 2334-1815
Launched : 2013
Journal of Ear, Nose and Throat Disorders
ISSN : 2475-9473
Launched : 2016
JSM Ophthalmology
ISSN : 2333-6447
Launched : 2013
Journal of Pharmacology and Clinical Toxicology
ISSN : 2333-7079
Launched : 2013
Annals of Psychiatry and Mental Health
ISSN : 2374-0124
Launched : 2013
Medical Journal of Obstetrics and Gynecology
ISSN : 2333-6439
Launched : 2013
Annals of Pediatrics and Child Health
ISSN : 2373-9312
Launched : 2013
JSM Clinical Pharmaceutics
ISSN : 2379-9498
Launched : 2014
JSM Foot and Ankle
ISSN : 2475-9112
Launched : 2016
JSM Alzheimer's Disease and Related Dementia
ISSN : 2378-9565
Launched : 2014
Journal of Addiction Medicine and Therapy
ISSN : 2333-665X
Launched : 2013
Annals of Public Health and Research
ISSN : 2378-9328
Launched : 2014
Annals of Orthopedics and Rheumatology
ISSN : 2373-9290
Launched : 2013
Journal of Clinical Nephrology and Research
ISSN : 2379-0652
Launched : 2014
Annals of Community Medicine and Practice
ISSN : 2475-9465
Launched : 2014
Annals of Biometrics and Biostatistics
ISSN : 2374-0116
Launched : 2013
JSM Clinical Case Reports
ISSN : 2373-9819
Launched : 2013
Journal of Cancer Biology and Research
ISSN : 2373-9436
Launched : 2013
Journal of Surgery and Transplantation Science
ISSN : 2379-0911
Launched : 2013
Journal of Dermatology and Clinical Research
ISSN : 2373-9371
Launched : 2013
JSM Gastroenterology and Hepatology
ISSN : 2373-9487
Launched : 2013
Annals of Nursing and Practice
ISSN : 2379-9501
Launched : 2014
JSM Dentistry
ISSN : 2333-7133
Launched : 2013
Author Information X